Clinical trials are complex by nature, scientifically, operationally, and financially. While much attention is given to data collection and patient safety, one critical element often underestimated is the management of budgets and invoicing. In multi-site, multi-phase trials, the financial side can quickly become unmanageable without the right tools. From tracking site payments to reconciling sponsor invoices, small inefficiencies can snowball

Ethics committees, known globally as Institutional Review Boards (IRBs), Research Ethics Committees (RECs) or similar, are the cornerstone of clinical trial integrity. Their work ensures that research is conducted ethically, safely, and with full respect for participants’ rights. But while trials have evolved significantly through digital transformation, many ethics review processes remain stuck in outdated workflows. Document submissions via email.

In today’s increasingly digital and decentralised research landscape, one question is becoming more urgent: Who really owns clinical trial data? As clinical trials evolve, often involving multiple sponsors, CROs, investigators, platforms, and even wearable devices, the lines of data ownership and control are becoming increasingly complex. Understanding how data is managed, accessed, and protected is essential for ensuring compliance, protecting